Contents
Medicare fraud enforcement history runs from the program’s launch through stronger whistleblower laws, coordinated investigations and efforts to stop false claims before payment. If you work in billing, compliance or healthcare finance, that history explains why the same business can face a payment review, a criminal investigation and a civil whistleblower case. Your knowledge of what happened inside the business can connect the claim to the decision behind it.
The major changes gave Medicare a civil whistleblower route, dedicated fraud-control funding and tools to stop suspicious payments. Those changes also joined investigations, audits and enforcement across federal, state and local agencies.
Medicare became law on July 30, 1965, and benefit payments began on July 1, 1966. The original program established hospital insurance under Part A and medical insurance under Part B. CMS’s historical milestones describe implementation with more than 19 million people enrolled.
The legislation also created Medicaid as a separate program. That distinction still matters when reading enforcement announcements: Medicare and Medicaid fraud can appear in the same investigation while involving different payments and agencies. A national health care fraud headline can reach both programs and private insurers.
Yes. The False Claims Act provides a civil route for pursuing false Medicare claims, including cases brought by whistleblowers. The False Claims Amendments Act of 1986, enacted on October 27, strengthened liability and private enforcement.
An employee’s account of false billing can become a qui tam case brought on the government’s behalf. The case can connect the false claim to the company’s decisions about what to bill.
The Health Insurance Portability and Accountability Act became law on August 21, 1996. It directed the Department of Health and Human Services and the Attorney General to establish the Health Care Fraud and Abuse Control program by January 1, 1997. The program joined investigations, audits and enforcement across federal, state and local agencies. The law also created a federal healthcare fraud offense covering public and private health benefit programs. The first Health Care Fraud and Abuse Control annual report covered fiscal year 1997 and appeared in January 1998.
A 2011 Congressional Research Service report, Medicare Program Integrity: Activities to Protect Medicare from Payment Errors, Fraud, and Abuse, explains what the funding changed. The fraud-control program supported enforcement and prosecution. The Medicare Integrity Program funded contractors working for the Centers for Medicare & Medicaid Services on audits and medical review. Before HIPAA, those activities competed with ordinary program operations for funding. The law gave fraud control a more stable financial base.
The Medicare Prescription Drug, Improvement, and Modernization Act became law on December 8, 2003. Part D prescription benefits began on January 1, 2006, following enrollment in the preceding year.
Part D introduced another place where the business’s records and the government’s payment could diverge. CMS pays plan sponsors in advance, then adjusts payments using prescription drug event data, actual costs and rebates or other price concessions. The pharmacy transaction feeds a later federal payment calculation.
For someone inside a plan or pharmacy benefit manager, the consequential record may be an adjustment, a rebate report or a certification. A prescription claim and a sponsor’s final federal payment describe different stages. The sponsor’s report can be as consequential as the prescription itself.
The history of Medicare fraud strike forces runs from a Miami-Dade operation to a national network that follows billing across regions. The teams combine claims analysis with investigative work.
The Medicare Fraud Strike Force is a network of prosecutors and investigators that combines claims analysis with investigative work to pursue healthcare fraud. Its first operation began in Miami-Dade County in March 2007, concentrating on durable medical equipment and HIV infusion therapy.
The original fraud-control report describes teams bringing together prosecutors, a licensed nurse, federal and state agents, and local police investigators. The Justice Department’s Fraud Section and the U.S. Attorney’s Office for the Southern District of Florida led the effort. The HHS Office of Inspector General and the FBI supplied investigators alongside state and local partners.
The combination matters. Claims show what a supplier billed. Clinical and investigative knowledge can explain whether the treatment or equipment behind those claims existed. Los Angeles became the next operating location in 2008.
HEAT and national healthcare fraud actions grew out of the same push for coordinated enforcement. HHS and the Justice Department announced the Health Care Fraud Prevention and Enforcement Action Team in May 2009, bringing the Strike Force model into a broader joint initiative.
Detroit and Houston joined the network that year, followed by Brooklyn, Tampa and Baton Rouge in December. On February 17, 2011, the departments added Dallas and Chicago, bringing the footprint to nine cities.
The criminal indictments and complaints described in that announcement alleged payments to patient recruiters and beneficiaries for information used to bill for unnecessary or nonexistent care. That is a pattern an insider can recognize at its source: the recruitment payment, the patient information and the bill are parts of the same alleged arrangement.
Congress also expanded the tools available before money left Medicare. The Affordable Care Act in 2010 added provider-screening requirements and authority to hold payments while credible fraud allegations were investigated. The Inspector General’s office could refer an allegation to CMS to hold payments while investigators pursued the underlying conduct.
National takedowns brought separate investigations together in coordinated announcements. The underlying work increasingly followed schemes across regions and payment streams.
In 2018, the Health Care Fraud Unit established its own Data Analytics Team. The National Rapid Response Strike Force followed in 2020 to pursue large schemes across jurisdictions. Prescription opioid forces added a specialized focus in Appalachia in 2018 and New England in 2022.
The technology developed alongside that organizational expansion. Medicare and the ACA: Fraud Control Efforts and Results, published by the Business and Health Administration Association in 2017, described predictive modeling’s move toward identifying suspicious claims before payment. That changes the government’s opportunity: intervene while a claim is awaiting payment, instead of beginning with money already gone.
A 2018 Journal of Big Data study, Big Data fraud detection using multiple medicare data sources, combined Part B, Part D and durable medical equipment data, using OIG exclusion records to label providers. The practical contribution was a way to examine a provider across different Medicare activities.
The same journal’s 2023 paper, Explainable machine learning models for Medicare fraud detection, found that selecting fewer data fields could preserve performance:
When fewer features are required, it is easier to understand and explain what sort of information a model uses.
Explainable machine learning models for Medicare fraud detection, Journal of Big Data, 2023
That is useful to an investigator who needs to understand why a provider stands out. An insider can supply the missing explanation: an altered order, an ignored warning or an instruction to keep billing. We connect those decisions to the orders, claims and payments that carry the evidence.
Shared claims and financial analysis became a larger part of the national effort, alongside new regional teams and a new fraud division. The effort brought analysts and investigative agencies together to examine claims and financial activity.
In June 2025, the Justice Department announced a Health Care Fraud Data Fusion Center to bring its analysts together with HHS-OIG, the FBI and other agencies. A Financial Intelligence Review Team formed that year to combine claims analysis with financial analysis.
The regional expansion continued in 2026. The West Coast force launched in April, joining Arizona, Nevada and Northern California.
On June 23, CMS and the Justice Department announced an agreement giving the Fraud Division cloud computing space within CMS’s Integrated Data Repository. The same announcement described Claims Core processing with electronic attestation and identity verification as under development.
In 2026, a Justice Department memorandum put the Health Care Fraud Unit under the direction of the new National Fraud Enforcement Division. The department’s later organizational rule gave the division authority over criminal healthcare fraud proceedings.
An enforcement announcement can show both enormous billing and a successful effort to stop payment. Gold Rush shows why the money that reached the scheme still matters.
Operation Gold Rush illustrates what earlier intervention can mean. In the criminal charges described in the Justice Department’s June 30, 2025 announcement, the alleged organization used straw owners to buy medical supply companies, then used stolen beneficiary identities to submit $10.6 billion in false Medicare claims for urinary catheters and other equipment.
The Health Care Fraud Unit’s analysts and their partners detected the unusual billing. HHS-OIG and CMS prevented the organization from receiving all but approximately $41 million of approximately $4.45 billion scheduled for Medicare payment. The release described $4.41 billion in escrow that HHS and CMS intended to seek to return to the Medicare trust fund. It also reported approximately $900 million paid by supplemental insurers. We see the problem with celebrating only the Medicare stop: the alleged scheme was still getting paid elsewhere.
The 2026 national action shows why enforcement follows the clinical record as well as the money. Criminal charges against a wound-product company’s sales executive described tissue bought from tissue banks and relabeled at a 2,000% markup, with prices up to $1,450 per square centimeter. The executive allegedly paid kickbacks of approximately 40% of that amount.
Those payments allegedly encouraged providers to target hospice patients and apply allografts without coordination with treating physicians, including to superficial wounds that did not need them. We see the incentive in those allegations: a higher tissue price meant a bigger kickback. The wound became a sales opportunity.
The Justice Department reported that its Data Analytics Team detected the spike in allograft payments. The charges described what allegedly happened to patients behind that spike. The history of better data tools still leads back to someone who knows what care was ordered, what was provided and why.
Before the new charges announced on June 23, 2026, the Justice Department said the Strike Force program had charged more than 6,200 defendants since its March 2007 start. Those defendants collectively billed federal health care programs and private insurers more than $45 billion. That is the scale of the billing behind the charges.
The False Claims Act remains the civil whistleblower route through this expanding enforcement system. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
An agency can see a billing pattern across providers. You may know who instructed staff to change the supporting record, who received a warning, or why a payment report left something out. That knowledge can connect the government’s view of the money with the decisions inside the business.
Speak with our whistleblower experts about the decisions behind the claims, whether you see them in your employer’s billing, patient records or payment reports. We build the case around the connection you can explain and bring in Medicare fraud whistleblower lawyers who understand the payment system involved. We stay beside you from that first conversation through the case.